Zevra Therapeutics, Inc. ZVRA Payments to Acquire Other Investments
Payments to Acquire Other Investments at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireOtherInvestments.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s payments to acquire other investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s payments to acquire other investments?
- Zevra Therapeutics, Inc. (ZVRA) reported payments to acquire other investments of $58.3M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s payments to acquire other investments changed year-over-year?
- Zevra Therapeutics, Inc.'s payments to acquire other investments increased by 692.2% year-over-year, from $7.36M to $58.3M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s payments to acquire other investments?
- Over 2 years (2023 to 2025), Zevra Therapeutics, Inc.'s payments to acquire other investments has grown at a 160.1% compound annual growth rate (CAGR), from $45.81M to $309.99M.